title: Activity-dependent alternative splicing increases persistent sodium current and promotes seizure.
abstract: Activity of voltage-gated Na channels (Na(v)) is modified by alternative splicing. However, whether altered splicing of human Na(v)s contributes to epilepsy remains to be conclusively shown. We show here that altered splicing of the Drosophila Na(v) (paralytic, DmNa(v)) contributes to seizure-like behavior in identified seizure mutants. We focus attention on a pair of mutually exclusive alternate exons (termed K and L), which form part of the voltage sensor (S4) in domain III of the expressed channel. The presence of exon L results in a large, non-inactivating, persistent I(Nap). Many forms of human epilepsy are associated with an increase in this current. In wild-type (WT) Drosophila larvae, ∼70-80% of DmNa(v) transcripts contain exon L, and the remainder contain exon K. Splicing of DmNa(v) to include exon L is increased to ∼100% in both the slamdance and easily-shocked seizure mutants. This change to splicing is prevented by reducing synaptic activity levels through exposure to the antiepileptic phenytoin or the inhibitory transmitter GABA. Conversely, enhancing synaptic activity in WT, by feeding of picrotoxin is sufficient to increase I(Nap) and promote seizure through increased inclusion of exon L to 100%. We also show that the underlying activity-dependent mechanism requires the presence of Pasilla, an RNA-binding protein. Finally, we use computational modeling to show that increasing I(Nap) is sufficient to potentiate membrane excitability consistent with a seizure phenotype. Thus, increased synaptic excitation favors inclusion of exon L, which, in turn, further increases neuronal excitability. Thus, at least in Drosophila, this self-reinforcing cycle may promote the incidence of seizure.
authors.affiliation: Faculty of Life Sciences, University of Manchester, Manchester M13 9PL, United Kingdom.
authors.forename: Wei-Hsiang
authors.initials: WH
authors.lastname: Lin
authors.forename: Cengiz
authors.initials: C
authors.lastname: Günay
authors.forename: Richard
authors.initials: R
authors.lastname: Marley
authors.forename: Astrid A
authors.initials: AA
authors.lastname: Prinz
authors.forename: Richard A
authors.initials: RA
authors.lastname: Baines
mesh_terms: D017398:Alternative Splicing / Q000502:physiology*; D000818:Animals; D029721:Drosophila Proteins / Q000235:genetics* / Q000502:physiology; D005091:Exons / Q000502:physiology*; D008564:Membrane Potentials / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D008969:Molecular Sequence Data; D050505:Mutant Proteins / Q000502:physiology; D010672:Phenytoin / Q000494:pharmacology; D010852:Picrotoxin / Q000494:pharmacology; D012261:Ribonucleoproteins / Q000502:physiology; D012640:Seizures / Q000235:genetics / Q000503:physiopathology*; D015222:Sodium Channels / Q000235:genetics / Q000502:physiology*; D009435:Synaptic Transmission / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
chemical_list: D029721:Drosophila Proteins; D050505:Mutant Proteins; D010672:Phenytoin; D010852:Picrotoxin; D012261:Ribonucleoproteins; D015222:Sodium Channels; D005680:gamma-Aminobutyric Acid; C469950:para protein, Drosophila; C445001:ps protein, Drosophila